Arsenic trioxide enhances the inhibitory effect of lenvatinib on hepatocellular carcinoma through HMOX1-mediated ferroptosis
International Immunopharmacology · 2025-12 · 167 · 115656
DOI: 10.1016/j.intimp.2025.115656 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-12. Verfasst von Shufang Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 20…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Arsenic Trioxide, Quinolines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China; Oncology Department of Traditional Chinese Medicine, the…
- Department of Traditional Chinese Medicine, PLA Navy No. 971 Hospital, Qingdao 266071, Shandong Province, China; Oncology Department of Traditional Chinese Medicine, the First Affiliated Hospital of Naval Medical Univer…
- Oncology Department of Traditional Chinese Medicine, the First Affiliated Hospital of Naval Medical University (Second Military Medical University), Shanghai 200433, China; The First Clinical Medical College of Shaanxi…
- Oncology Department of Traditional Chinese Medicine, the First Affiliated Hospital of Naval Medical University (Second Military Medical University), Shanghai 200433, China.
- Faculty of Traditional Chinese Medicine, Naval Medical University (Second Military Medical University), Shanghai 200433, China.
- Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China. Electronic address: tjhhawk@shutcm.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liang, S., Huang, G., Fu, M., Shi, Y., Tu, X., Lin, W., Tian, J., Zhai, X., & Cheng, B. (2025). Arsenic trioxide enhances the inhibitory effect of lenvatinib on hepatocellular carcinoma through HMOX1-mediated ferroptosis. International Immunopharmacology, 167, 115656. https://doi.org/10.1016/j.intimp.2025.115656
Vancouver
Liang S, Huang G, Fu M, Shi Y, Tu X, Lin W, et al. Arsenic trioxide enhances the inhibitory effect of lenvatinib on hepatocellular carcinoma through HMOX1-mediated ferroptosis. International Immunopharmacology. 2025;167:115656. doi:10.1016/j.intimp.2025.115656
BibTeX
@article{Liang2025,
author = {Liang, Shufang and Huang, Guokai and Fu, Meihuan and Shi, Yuanrong and Tu, Xiaoyu and Lin, Wanfu and Tian, Jianhui and Zhai, Xiaofeng and Cheng, Binbin},
title = {Arsenic trioxide enhances the inhibitory effect of lenvatinib on hepatocellular carcinoma through HMOX1-mediated ferroptosis},
journal = {International Immunopharmacology},
year = {2025},
volume = {167},
pages = {115656},
doi = {10.1016/j.intimp.2025.115656}
}
EUVIMED